AU2001252269A1 - Chromenylmethyl pyrimidinediamines as antibacterial agents - Google Patents
Chromenylmethyl pyrimidinediamines as antibacterial agentsInfo
- Publication number
- AU2001252269A1 AU2001252269A1 AU2001252269A AU5226901A AU2001252269A1 AU 2001252269 A1 AU2001252269 A1 AU 2001252269A1 AU 2001252269 A AU2001252269 A AU 2001252269A AU 5226901 A AU5226901 A AU 5226901A AU 2001252269 A1 AU2001252269 A1 AU 2001252269A1
- Authority
- AU
- Australia
- Prior art keywords
- dimethyl
- chromen
- ylmethyl
- methoxy
- ethoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000003242 anti bacterial agent Substances 0.000 title description 2
- YAAWASYJIRZXSZ-UHFFFAOYSA-N pyrimidine-2,4-diamine Chemical class NC1=CC=NC(N)=N1 YAAWASYJIRZXSZ-UHFFFAOYSA-N 0.000 title description 2
- 150000001875 compounds Chemical class 0.000 claims abstract description 96
- 150000003839 salts Chemical class 0.000 claims abstract description 26
- 238000004519 manufacturing process Methods 0.000 claims abstract description 15
- 239000003814 drug Substances 0.000 claims abstract description 13
- 239000000126 substance Substances 0.000 claims abstract description 7
- 150000008371 chromenes Chemical class 0.000 claims abstract description 3
- -1 alkoxyalkynyl Chemical group 0.000 claims description 41
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 41
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 17
- 125000000217 alkyl group Chemical group 0.000 claims description 15
- 229910052794 bromium Inorganic materials 0.000 claims description 15
- 229910052736 halogen Inorganic materials 0.000 claims description 12
- 150000002367 halogens Chemical group 0.000 claims description 12
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 claims description 8
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 7
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 7
- 125000000524 functional group Chemical group 0.000 claims description 6
- 125000001072 heteroaryl group Chemical group 0.000 claims description 6
- 125000000623 heterocyclic group Chemical group 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 125000003118 aryl group Chemical group 0.000 claims description 5
- 125000001246 bromo group Chemical group Br* 0.000 claims description 5
- 125000002837 carbocyclic group Chemical group 0.000 claims description 5
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 5
- 125000006239 protecting group Chemical group 0.000 claims description 5
- 238000011282 treatment Methods 0.000 claims description 5
- MGADZUXDNSDTHW-UHFFFAOYSA-N 2H-pyran Chemical compound C1OC=CC=C1 MGADZUXDNSDTHW-UHFFFAOYSA-N 0.000 claims description 4
- UXGWEACVEQDIIR-UHFFFAOYSA-N 5-[(8-methoxy-2,2-dimethyl-4-methylsulfanylchromen-6-yl)methyl]pyrimidine-2,4-diamine Chemical compound C=1C=2C(SC)=CC(C)(C)OC=2C(OC)=CC=1CC1=CN=C(N)N=C1N UXGWEACVEQDIIR-UHFFFAOYSA-N 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 claims description 4
- 125000004414 alkyl thio group Chemical group 0.000 claims description 4
- 125000000304 alkynyl group Chemical group 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims description 4
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 claims description 4
- 229920006395 saturated elastomer Polymers 0.000 claims description 4
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 claims description 4
- 229940124530 sulfonamide Drugs 0.000 claims description 4
- BAYDPQRUPRTXJV-UHFFFAOYSA-N 5-[(4-bromo-8-ethoxy-2,2-dimethylchromen-6-yl)methyl]pyrimidine-2,4-diamine Chemical compound C=1C=2C(Br)=CC(C)(C)OC=2C(OCC)=CC=1CC1=CN=C(N)N=C1N BAYDPQRUPRTXJV-UHFFFAOYSA-N 0.000 claims description 3
- CIEOBODUUABEGI-UHFFFAOYSA-N 5-[(4-bromo-8-methoxy-2,2-dimethylchromen-6-yl)methyl]pyrimidine-2,4-diamine Chemical compound C=1C=2C(Br)=CC(C)(C)OC=2C(OC)=CC=1CC1=CN=C(N)N=C1N CIEOBODUUABEGI-UHFFFAOYSA-N 0.000 claims description 3
- VSJGJTFTPPQZRO-UHFFFAOYSA-N 5-[(4-chloro-8-methoxy-2,2-dimethylchromen-6-yl)methyl]pyrimidine-2,4-diamine Chemical compound C=1C=2C(Cl)=CC(C)(C)OC=2C(OC)=CC=1CC1=CN=C(N)N=C1N VSJGJTFTPPQZRO-UHFFFAOYSA-N 0.000 claims description 3
- SWJJNJQGSMROBJ-UHFFFAOYSA-N 5-[(8-ethoxy-2,2,4-trimethylchromen-6-yl)methyl]pyrimidine-2,4-diamine Chemical compound C=1C=2C(C)=CC(C)(C)OC=2C(OCC)=CC=1CC1=CN=C(N)N=C1N SWJJNJQGSMROBJ-UHFFFAOYSA-N 0.000 claims description 3
- XXUYEERDOBVMTA-UHFFFAOYSA-N 5-[(8-ethoxy-2,2-dimethyl-4-propylchromen-6-yl)methyl]pyrimidine-2,4-diamine Chemical compound C1=C2C(CCC)=CC(C)(C)OC2=C(OCC)C=C1CC1=CN=C(N)N=C1N XXUYEERDOBVMTA-UHFFFAOYSA-N 0.000 claims description 3
- RICKLMXZWGPFEH-UHFFFAOYSA-N 5-[(8-ethoxy-4-ethyl-2,2-dimethylchromen-6-yl)methyl]pyrimidine-2,4-diamine Chemical compound C=1C=2C(CC)=CC(C)(C)OC=2C(OCC)=CC=1CC1=CN=C(N)N=C1N RICKLMXZWGPFEH-UHFFFAOYSA-N 0.000 claims description 3
- DSDHQJZBYGTHTE-UHFFFAOYSA-N 5-[[8-methoxy-4-(3-methoxyprop-1-ynyl)-2,2-dimethylchromen-6-yl]methyl]pyrimidine-2,4-diamine Chemical compound C1=C2C(C#CCOC)=CC(C)(C)OC2=C(OC)C=C1CC1=CN=C(N)N=C1N DSDHQJZBYGTHTE-UHFFFAOYSA-N 0.000 claims description 3
- 208000035473 Communicable disease Diseases 0.000 claims description 3
- 125000003342 alkenyl group Chemical group 0.000 claims description 3
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 3
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 3
- 125000004665 trialkylsilyl group Chemical group 0.000 claims description 3
- 125000004008 6 membered carbocyclic group Chemical group 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 150000002431 hydrogen Chemical group 0.000 claims description 2
- 125000005016 hydroxyalkynyl group Chemical group 0.000 claims description 2
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims description 2
- 150000001721 carbon Chemical group 0.000 claims 2
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 239000002253 acid Substances 0.000 abstract description 19
- 239000000543 intermediate Substances 0.000 abstract description 19
- 150000003456 sulfonamides Chemical class 0.000 abstract description 7
- 239000013543 active substance Substances 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 105
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 88
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 64
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 63
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 58
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 50
- 239000013078 crystal Substances 0.000 description 50
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 49
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 48
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 48
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 47
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 44
- 235000019341 magnesium sulphate Nutrition 0.000 description 44
- 239000011541 reaction mixture Substances 0.000 description 39
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 38
- 239000012267 brine Substances 0.000 description 38
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 38
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 36
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 35
- 238000003818 flash chromatography Methods 0.000 description 34
- 229910052681 coesite Inorganic materials 0.000 description 32
- 229910052906 cristobalite Inorganic materials 0.000 description 32
- 229910052682 stishovite Inorganic materials 0.000 description 32
- 229910052905 tridymite Inorganic materials 0.000 description 32
- 239000000377 silicon dioxide Substances 0.000 description 31
- 239000002904 solvent Substances 0.000 description 29
- 238000006243 chemical reaction Methods 0.000 description 27
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 27
- 238000001704 evaporation Methods 0.000 description 26
- 230000008020 evaporation Effects 0.000 description 26
- 238000001035 drying Methods 0.000 description 25
- 238000005406 washing Methods 0.000 description 25
- 235000002639 sodium chloride Nutrition 0.000 description 23
- 239000007787 solid Substances 0.000 description 23
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 22
- 238000000605 extraction Methods 0.000 description 22
- 239000003921 oil Substances 0.000 description 22
- 235000019198 oils Nutrition 0.000 description 22
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 17
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 16
- 239000012043 crude product Substances 0.000 description 15
- FENJKTQEFUPECW-UHFFFAOYSA-N 3-anilinopropanenitrile Chemical compound N#CCCNC1=CC=CC=C1 FENJKTQEFUPECW-UHFFFAOYSA-N 0.000 description 13
- 239000012300 argon atmosphere Substances 0.000 description 13
- 229960000789 guanidine hydrochloride Drugs 0.000 description 13
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 12
- 229910052938 sodium sulfate Inorganic materials 0.000 description 12
- 235000011152 sodium sulphate Nutrition 0.000 description 12
- 239000007858 starting material Substances 0.000 description 12
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 11
- 150000001241 acetals Chemical class 0.000 description 11
- 239000012044 organic layer Substances 0.000 description 11
- 238000004817 gas chromatography Methods 0.000 description 10
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 9
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 9
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 9
- 239000002585 base Substances 0.000 description 9
- 239000000460 chlorine Substances 0.000 description 9
- 238000002425 crystallisation Methods 0.000 description 9
- 239000012039 electrophile Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 239000012876 carrier material Substances 0.000 description 8
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 8
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 8
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 7
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 7
- 108010022394 Threonine synthase Proteins 0.000 description 7
- 150000001299 aldehydes Chemical class 0.000 description 7
- 230000000844 anti-bacterial effect Effects 0.000 description 7
- 239000003054 catalyst Substances 0.000 description 7
- 229910052801 chlorine Inorganic materials 0.000 description 7
- 230000008025 crystallization Effects 0.000 description 7
- 102000004419 dihydrofolate reductase Human genes 0.000 description 7
- 239000011737 fluorine Substances 0.000 description 7
- 229910052731 fluorine Inorganic materials 0.000 description 7
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 7
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 7
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 6
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 6
- 125000003545 alkoxy group Chemical group 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 6
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 6
- MFYSUUPKMDJYPF-UHFFFAOYSA-N 2-[(4-methyl-2-nitrophenyl)diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC1=CC=C(C)C=C1[N+]([O-])=O MFYSUUPKMDJYPF-UHFFFAOYSA-N 0.000 description 5
- FBBCSYADXYILEH-UHFFFAOYSA-N 4-hydroxy-3-iodo-5-methoxybenzaldehyde Chemical compound COC1=CC(C=O)=CC(I)=C1O FBBCSYADXYILEH-UHFFFAOYSA-N 0.000 description 5
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 5
- 125000005236 alkanoylamino group Chemical group 0.000 description 5
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- 229910000404 tripotassium phosphate Inorganic materials 0.000 description 5
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 4
- WFAHCDLEWJKPJS-UHFFFAOYSA-N 3-ethoxy-4-hydroxy-5-iodobenzaldehyde Chemical compound CCOC1=CC(C=O)=CC(I)=C1O WFAHCDLEWJKPJS-UHFFFAOYSA-N 0.000 description 4
- HNVRRHSXBLFLIG-UHFFFAOYSA-N 3-hydroxy-3-methylbut-1-ene Chemical compound CC(C)(O)C=C HNVRRHSXBLFLIG-UHFFFAOYSA-N 0.000 description 4
- 239000001828 Gelatine Substances 0.000 description 4
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 241000193998 Streptococcus pneumoniae Species 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 239000007859 condensation product Substances 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 150000003077 polyols Chemical class 0.000 description 4
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 4
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 4
- 229960005404 sulfamethoxazole Drugs 0.000 description 4
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- FTVLMFQEYACZNP-UHFFFAOYSA-N trimethylsilyl trifluoromethanesulfonate Chemical compound C[Si](C)(C)OS(=O)(=O)C(F)(F)F FTVLMFQEYACZNP-UHFFFAOYSA-N 0.000 description 4
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- JQGKGZPSTIGWGQ-UHFFFAOYSA-N 4-bromo-8-ethoxy-2,2-dimethylchromene-6-carbaldehyde Chemical compound BrC1=CC(C)(C)OC2=C1C=C(C=O)C=C2OCC JQGKGZPSTIGWGQ-UHFFFAOYSA-N 0.000 description 3
- ONKWEGUKYJSTJW-UHFFFAOYSA-N 4-bromo-8-methoxy-2,2-dimethylchromene-6-carbaldehyde Chemical compound BrC1=CC(C)(C)OC2=C1C=C(C=O)C=C2OC ONKWEGUKYJSTJW-UHFFFAOYSA-N 0.000 description 3
- LBUNNMJLXWQQBY-UHFFFAOYSA-N 4-fluorophenylboronic acid Chemical compound OB(O)C1=CC=C(F)C=C1 LBUNNMJLXWQQBY-UHFFFAOYSA-N 0.000 description 3
- KITPJENAFLVONE-UHFFFAOYSA-N 8-ethoxy-4-(2-hydroxypropan-2-yl)-2,2-dimethylchromene-6-carbaldehyde Chemical compound CC(O)(C)C1=CC(C)(C)OC2=C1C=C(C=O)C=C2OCC KITPJENAFLVONE-UHFFFAOYSA-N 0.000 description 3
- UMPRIBRTTYVHCK-UHFFFAOYSA-N 8-methoxy-2,2,4-trimethylchromene-6-carbaldehyde Chemical compound CC1=CC(C)(C)OC2=C1C=C(C=O)C=C2OC UMPRIBRTTYVHCK-UHFFFAOYSA-N 0.000 description 3
- IRMONAYMIVIKDK-UHFFFAOYSA-N 8-methoxy-2,2-dimethylchromene-6-carbaldehyde Chemical compound C1=CC(C)(C)OC2=C1C=C(C=O)C=C2OC IRMONAYMIVIKDK-UHFFFAOYSA-N 0.000 description 3
- DZSABHPZBZDGLW-UHFFFAOYSA-N 8-methoxyspiro[chromene-2,4'-oxane]-6-carbaldehyde Chemical compound O1C=2C(OC)=CC(C=O)=CC=2C=CC21CCOCC2 DZSABHPZBZDGLW-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 238000006069 Suzuki reaction reaction Methods 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Substances N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 239000007819 coupling partner Substances 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 238000007306 functionalization reaction Methods 0.000 description 3
- 229960004198 guanidine Drugs 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 3
- 239000012442 inert solvent Substances 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229910052763 palladium Inorganic materials 0.000 description 3
- LXNAVEXFUKBNMK-UHFFFAOYSA-N palladium(II) acetate Substances [Pd].CC(O)=O.CC(O)=O LXNAVEXFUKBNMK-UHFFFAOYSA-N 0.000 description 3
- 238000007911 parenteral administration Methods 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- KQDJTBPASNJQFQ-UHFFFAOYSA-N 2-iodophenol Chemical compound OC1=CC=CC=C1I KQDJTBPASNJQFQ-UHFFFAOYSA-N 0.000 description 2
- IBGBGRVKPALMCQ-UHFFFAOYSA-N 3,4-dihydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1O IBGBGRVKPALMCQ-UHFFFAOYSA-N 0.000 description 2
- AYWDOTWLZYHFTI-UHFFFAOYSA-N 3-amino-2-[[8-ethoxy-4-(3-hydroxyprop-1-ynyl)-2,2-dimethylchromen-6-yl]methyl]-3-phenylprop-2-enenitrile Chemical compound C=1C=2C(C#CCO)=CC(C)(C)OC=2C(OCC)=CC=1CC(C#N)=C(N)C1=CC=CC=C1 AYWDOTWLZYHFTI-UHFFFAOYSA-N 0.000 description 2
- MQCVEUSRVYGFTA-UHFFFAOYSA-N 3-anilino-2-[(2-cyclopropyl-8-ethoxy-2-methylchromen-6-yl)methyl]prop-2-enenitrile Chemical compound C=1C=2C=CC(C)(C3CC3)OC=2C(OCC)=CC=1CC(C#N)=CNC1=CC=CC=C1 MQCVEUSRVYGFTA-UHFFFAOYSA-N 0.000 description 2
- AWBKRRJOQXGOFI-UHFFFAOYSA-N 3-anilino-2-[(4-bromo-8-methoxy-2,2-dimethylchromen-6-yl)methyl]prop-2-enenitrile Chemical compound C=1C=2C(Br)=CC(C)(C)OC=2C(OC)=CC=1CC(C#N)=CNC1=CC=CC=C1 AWBKRRJOQXGOFI-UHFFFAOYSA-N 0.000 description 2
- CBMOTIKFSONDLU-UHFFFAOYSA-N 3-anilino-2-[(8-methoxy-2,2,4-trimethylchromen-6-yl)methyl]prop-2-enenitrile Chemical compound C=1C=2C(C)=CC(C)(C)OC=2C(OC)=CC=1CC(C#N)=CNC1=CC=CC=C1 CBMOTIKFSONDLU-UHFFFAOYSA-N 0.000 description 2
- HSDGELHHUGCZDY-UHFFFAOYSA-N 4-(4-fluorophenyl)-8-methoxy-2,2-dimethylchromene-6-carbaldehyde Chemical compound C=1C(C)(C)OC=2C(OC)=CC(C=O)=CC=2C=1C1=CC=C(F)C=C1 HSDGELHHUGCZDY-UHFFFAOYSA-N 0.000 description 2
- FOQARNKJDNWSAK-UHFFFAOYSA-N 4-(8-ethoxy-6-formyl-2,2-dimethylchromen-4-yl)benzonitrile Chemical compound C=1C(C)(C)OC=2C(OCC)=CC(C=O)=CC=2C=1C1=CC=C(C#N)C=C1 FOQARNKJDNWSAK-UHFFFAOYSA-N 0.000 description 2
- NMKYHTLUVWXCBO-UHFFFAOYSA-N 4-(hydroxymethyl)-8-methoxy-2,2-dimethylchromene-6-carbaldehyde Chemical compound OCC1=CC(C)(C)OC2=C1C=C(C=O)C=C2OC NMKYHTLUVWXCBO-UHFFFAOYSA-N 0.000 description 2
- SBQQUBMTHFCTBP-UHFFFAOYSA-N 4-ethenyloxan-4-ol Chemical compound C=CC1(O)CCOCC1 SBQQUBMTHFCTBP-UHFFFAOYSA-N 0.000 description 2
- LOUYGYYLVYMECR-UHFFFAOYSA-N 5-[[4-(4-fluorophenyl)-8-methoxy-2,2-dimethylchromen-6-yl]methyl]pyrimidine-2,4-diamine Chemical compound C=1C=2C(C=3C=CC(F)=CC=3)=CC(C)(C)OC=2C(OC)=CC=1CC1=CN=C(N)N=C1N LOUYGYYLVYMECR-UHFFFAOYSA-N 0.000 description 2
- RODLPDCALOUSDI-UHFFFAOYSA-N 8-ethoxy-2,2-dimethylchromene-6-carbaldehyde Chemical compound C1=CC(C)(C)OC2=C1C=C(C=O)C=C2OCC RODLPDCALOUSDI-UHFFFAOYSA-N 0.000 description 2
- CHQGGLCHKVKYBK-UHFFFAOYSA-N 8-ethoxy-4-(3-hydroxyprop-1-ynyl)-2,2-dimethylchromene-6-carbaldehyde Chemical compound OCC#CC1=CC(C)(C)OC2=C1C=C(C=O)C=C2OCC CHQGGLCHKVKYBK-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 229930040373 Paraformaldehyde Natural products 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 206010041925 Staphylococcal infections Diseases 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 125000005418 aryl aryl group Chemical group 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 235000011089 carbon dioxide Nutrition 0.000 description 2
- 229960004424 carbon dioxide Drugs 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
- 230000005595 deprotonation Effects 0.000 description 2
- 238000010537 deprotonation reaction Methods 0.000 description 2
- WQOXQRCZOLPYPM-UHFFFAOYSA-N dimethyl disulfide Chemical compound CSSC WQOXQRCZOLPYPM-UHFFFAOYSA-N 0.000 description 2
- 239000008298 dragée Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 229940057948 magnesium stearate Drugs 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 125000006606 n-butoxy group Chemical group 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229920002866 paraformaldehyde Polymers 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 2
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 2
- IVDFJHOHABJVEH-UHFFFAOYSA-N pinacol Chemical compound CC(C)(O)C(C)(C)O IVDFJHOHABJVEH-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- ZDYVRSLAEXCVBX-UHFFFAOYSA-N pyridinium p-toluenesulfonate Chemical compound C1=CC=[NH+]C=C1.CC1=CC=C(S([O-])(=O)=O)C=C1 ZDYVRSLAEXCVBX-UHFFFAOYSA-N 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 125000003003 spiro group Chemical group 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- AYEKOFBPNLCAJY-UHFFFAOYSA-O thiamine pyrophosphate Chemical compound CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N AYEKOFBPNLCAJY-UHFFFAOYSA-O 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- IBTSWKLSEOGJGJ-UHFFFAOYSA-N (3-acetamidophenyl)boronic acid Chemical compound CC(=O)NC1=CC=CC(B(O)O)=C1 IBTSWKLSEOGJGJ-UHFFFAOYSA-N 0.000 description 1
- KNXQDJCZSVHEIW-UHFFFAOYSA-N (3-fluorophenyl)boronic acid Chemical compound OB(O)C1=CC=CC(F)=C1 KNXQDJCZSVHEIW-UHFFFAOYSA-N 0.000 description 1
- CEBAHYWORUOILU-UHFFFAOYSA-N (4-cyanophenyl)boronic acid Chemical compound OB(O)C1=CC=C(C#N)C=C1 CEBAHYWORUOILU-UHFFFAOYSA-N 0.000 description 1
- WRQNDLDUNQMTCL-UHFFFAOYSA-N (4-ethoxyphenyl)boronic acid Chemical compound CCOC1=CC=C(B(O)O)C=C1 WRQNDLDUNQMTCL-UHFFFAOYSA-N 0.000 description 1
- 125000004972 1-butynyl group Chemical group [H]C([H])([H])C([H])([H])C#C* 0.000 description 1
- NENZDZJSFGHDNG-UHFFFAOYSA-N 1-ethenylcyclobutan-1-ol Chemical compound C=CC1(O)CCC1 NENZDZJSFGHDNG-UHFFFAOYSA-N 0.000 description 1
- ZXKHOVDDJMJXQP-UHFFFAOYSA-N 1-ethenylcyclohexan-1-ol Chemical compound C=CC1(O)CCCCC1 ZXKHOVDDJMJXQP-UHFFFAOYSA-N 0.000 description 1
- BTUGGGLMQBJCBN-UHFFFAOYSA-N 1-iodo-2-methylpropane Chemical compound CC(C)CI BTUGGGLMQBJCBN-UHFFFAOYSA-N 0.000 description 1
- 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 description 1
- VOFVONJHZBDEFT-UHFFFAOYSA-N 2'-methoxyspiro[chromene-2,4'-oxane]-6-carbaldehyde Chemical compound C1COC(OC)CC21C=CC1=CC(C=O)=CC=C1O2 VOFVONJHZBDEFT-UHFFFAOYSA-N 0.000 description 1
- CTPDSKVQLSDPLC-UHFFFAOYSA-N 2-(oxolan-2-ylmethoxy)ethanol Chemical compound OCCOCC1CCCO1 CTPDSKVQLSDPLC-UHFFFAOYSA-N 0.000 description 1
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 1
- DOSOTGSDNVUDDZ-UHFFFAOYSA-N 2-[6-[(2,4-diaminopyrimidin-5-yl)methyl]-8-ethoxy-2,2-dimethylchromen-4-yl]butan-2-ol Chemical compound C=1C=2C(C(C)(O)CC)=CC(C)(C)OC=2C(OCC)=CC=1CC1=CN=C(N)N=C1N DOSOTGSDNVUDDZ-UHFFFAOYSA-N 0.000 description 1
- POCZDEAHDOTYEQ-UHFFFAOYSA-N 2-[6-[(2,4-diaminopyrimidin-5-yl)methyl]-8-ethoxy-2,2-dimethylchromen-4-yl]propan-2-ol Chemical compound C=1C=2C(C(C)(C)O)=CC(C)(C)OC=2C(OCC)=CC=1CC1=CN=C(N)N=C1N POCZDEAHDOTYEQ-UHFFFAOYSA-N 0.000 description 1
- AMFSJVJTVJYFBE-UHFFFAOYSA-N 2-amino-n-(4,5-dimethyl-1,2-oxazol-3-yl)benzenesulfonamide Chemical compound CC1=C(C)ON=C1NS(=O)(=O)C1=CC=CC=C1N AMFSJVJTVJYFBE-UHFFFAOYSA-N 0.000 description 1
- AZVRQGHQVPBIHL-UHFFFAOYSA-N 2-amino-n-(4,5-dimethylpyrimidin-2-yl)benzenesulfonamide Chemical compound N1=C(C)C(C)=CN=C1NS(=O)(=O)C1=CC=CC=C1N AZVRQGHQVPBIHL-UHFFFAOYSA-N 0.000 description 1
- MSDUZQKPOYKTKB-UHFFFAOYSA-N 2-cyclopropyl-8-ethoxy-2-methylchromene-6-carbaldehyde Chemical compound O1C=2C(OCC)=CC(C=O)=CC=2C=CC1(C)C1CC1 MSDUZQKPOYKTKB-UHFFFAOYSA-N 0.000 description 1
- JGQHOTLHQMUQDR-UHFFFAOYSA-N 2-cyclopropylbut-3-en-2-ol Chemical compound C=CC(O)(C)C1CC1 JGQHOTLHQMUQDR-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- PCYGLFXKCBFGPC-UHFFFAOYSA-N 3,4-Dihydroxy hydroxymethyl benzene Natural products OCC1=CC=C(O)C(O)=C1 PCYGLFXKCBFGPC-UHFFFAOYSA-N 0.000 description 1
- ZUUZNOFTKGDLLN-UHFFFAOYSA-N 3-(1,3,2-dioxaborinan-2-yl)pyridine Chemical compound O1CCCOB1C1=CC=CN=C1 ZUUZNOFTKGDLLN-UHFFFAOYSA-N 0.000 description 1
- LNASUJDZHAUORD-UHFFFAOYSA-N 3-[6-[(2,4-diaminopyrimidin-5-yl)methyl]-8-ethoxy-2,2-dimethylchromen-4-yl]prop-2-yn-1-ol Chemical compound C=1C=2C(C#CCO)=CC(C)(C)OC=2C(OCC)=CC=1CC1=CN=C(N)N=C1N LNASUJDZHAUORD-UHFFFAOYSA-N 0.000 description 1
- OMGOBXQTGUAOEQ-UHFFFAOYSA-N 3-[6-[(2,4-diaminopyrimidin-5-yl)methyl]-8-methoxy-2,2-dimethylchromen-4-yl]prop-2-yn-1-ol Chemical compound C=1C=2C(C#CCO)=CC(C)(C)OC=2C(OC)=CC=1CC1=CN=C(N)N=C1N OMGOBXQTGUAOEQ-UHFFFAOYSA-N 0.000 description 1
- NZJKUCRTHVDCJT-UHFFFAOYSA-N 3-anilino-2-[(8-bromo-2,2,4-trimethylchromen-6-yl)methyl]prop-2-enenitrile Chemical compound C1=C2C(C)=CC(C)(C)OC2=C(Br)C=C1CC(C#N)=CNC1=CC=CC=C1 NZJKUCRTHVDCJT-UHFFFAOYSA-N 0.000 description 1
- 125000000474 3-butynyl group Chemical group [H]C#CC([H])([H])C([H])([H])* 0.000 description 1
- ZNRGSYUVFVNSAW-UHFFFAOYSA-N 3-nitrophenylboronic acid Chemical compound OB(O)C1=CC=CC([N+]([O-])=O)=C1 ZNRGSYUVFVNSAW-UHFFFAOYSA-N 0.000 description 1
- HZXGYUGSPOXVFU-UHFFFAOYSA-N 4-[6-[(2,4-diaminopyrimidin-5-yl)methyl]-8-ethoxy-2,2-dimethylchromen-4-yl]benzonitrile Chemical compound C=1C=2C(C=3C=CC(=CC=3)C#N)=CC(C)(C)OC=2C(OCC)=CC=1CC1=CN=C(N)N=C1N HZXGYUGSPOXVFU-UHFFFAOYSA-N 0.000 description 1
- MZQUTOQQNLUGKK-UHFFFAOYSA-N 4-[6-[(2,4-diaminopyrimidin-5-yl)methyl]-8-ethoxy-2,2-dimethylchromen-4-yl]but-3-yn-2-ol Chemical compound C=1C=2C(C#CC(C)O)=CC(C)(C)OC=2C(OCC)=CC=1CC1=CN=C(N)N=C1N MZQUTOQQNLUGKK-UHFFFAOYSA-N 0.000 description 1
- NHZLNPMOSADWGC-UHFFFAOYSA-N 4-amino-N-(2-quinoxalinyl)benzenesulfonamide Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=CN=C(C=CC=C2)C2=N1 NHZLNPMOSADWGC-UHFFFAOYSA-N 0.000 description 1
- ORWKAFKIAPHHBG-UHFFFAOYSA-N 4-amino-n-(4,5-dimethoxypyrimidin-2-yl)benzenesulfonamide Chemical compound N1=C(OC)C(OC)=CN=C1NS(=O)(=O)C1=CC=C(N)C=C1 ORWKAFKIAPHHBG-UHFFFAOYSA-N 0.000 description 1
- LYSDZKNFRBLKKB-UHFFFAOYSA-N 4-bromo-8-methoxyspiro[chromene-2,4'-oxane] Chemical compound BrC1=CC2(CCOCC2)OC2=C1C=CC=C2OC LYSDZKNFRBLKKB-UHFFFAOYSA-N 0.000 description 1
- PDLMGAIHXWWWOF-UHFFFAOYSA-N 4-bromo-8-methoxyspiro[chromene-2,4'-oxane]-6-carbaldehyde Chemical compound O1C=2C(OC)=CC(C=O)=CC=2C(Br)=CC21CCOCC2 PDLMGAIHXWWWOF-UHFFFAOYSA-N 0.000 description 1
- YRPMWNQZAHRXFR-UHFFFAOYSA-N 4-chloro-8-methoxy-2,2-dimethylchromene-6-carbaldehyde Chemical compound ClC1=CC(C)(C)OC2=C1C=C(C=O)C=C2OC YRPMWNQZAHRXFR-UHFFFAOYSA-N 0.000 description 1
- NFTNCIPPEYAHMC-UHFFFAOYSA-N 4-ethenyl-4-hydroxypiperidine-1-carboxylic acid Chemical compound OC(=O)N1CCC(O)(C=C)CC1 NFTNCIPPEYAHMC-UHFFFAOYSA-N 0.000 description 1
- VYOOMQPHRDSKGY-UHFFFAOYSA-N 5-[(4-bromo-8-methoxyspiro[chromene-2,4'-piperidine]-6-yl)methyl]pyrimidine-2,4-diamine Chemical compound C=1C=2C(Br)=CC3(CCNCC3)OC=2C(OC)=CC=1CC1=CN=C(N)N=C1N VYOOMQPHRDSKGY-UHFFFAOYSA-N 0.000 description 1
- DBYUPMUKMQBJDL-UHFFFAOYSA-N 5-[(4-chloro-8-ethoxy-2,2-dimethylchromen-6-yl)methyl]pyrimidine-2,4-diamine Chemical compound C=1C=2C(Cl)=CC(C)(C)OC=2C(OCC)=CC=1CC1=CN=C(N)N=C1N DBYUPMUKMQBJDL-UHFFFAOYSA-N 0.000 description 1
- WPDILLMCLKPWLC-UHFFFAOYSA-N 5-[(4-ethyl-8-methoxy-2,2-dimethylchromen-6-yl)methyl]pyrimidine-2,4-diamine Chemical compound C1=C2C(CC)=CC(C)(C)OC2=C(OC)C=C1CC1=CN=C(N)N=C1N WPDILLMCLKPWLC-UHFFFAOYSA-N 0.000 description 1
- RZLGYWDMQZRVBR-UHFFFAOYSA-N 5-[(8-ethoxy-2,2-dimethyl-4-methylsulfanylchromen-6-yl)methyl]pyrimidine-2,4-diamine Chemical compound C=1C=2C(SC)=CC(C)(C)OC=2C(OCC)=CC=1CC1=CN=C(N)N=C1N RZLGYWDMQZRVBR-UHFFFAOYSA-N 0.000 description 1
- KUOXPFNBDQJLEP-UHFFFAOYSA-N 5-[(8-ethoxy-2,2-dimethyl-4-prop-1-en-2-ylchromen-6-yl)methyl]pyrimidine-2,4-diamine Chemical compound C=1C=2C(C(C)=C)=CC(C)(C)OC=2C(OCC)=CC=1CC1=CN=C(N)N=C1N KUOXPFNBDQJLEP-UHFFFAOYSA-N 0.000 description 1
- LTUOXQCJJRJYMS-UHFFFAOYSA-N 5-[(8-ethoxy-2,2-dimethyl-4-pyridin-3-ylchromen-6-yl)methyl]pyrimidine-2,4-diamine Chemical compound C=1C=2C(C=3C=NC=CC=3)=CC(C)(C)OC=2C(OCC)=CC=1CC1=CN=C(N)N=C1N LTUOXQCJJRJYMS-UHFFFAOYSA-N 0.000 description 1
- WEFXJAAWRSVZGQ-UHFFFAOYSA-N 5-[(8-ethoxy-2,2-dimethyl-4-pyridin-4-ylchromen-6-yl)methyl]pyrimidine-2,4-diamine Chemical compound C=1C=2C(C=3C=CN=CC=3)=CC(C)(C)OC=2C(OCC)=CC=1CC1=CN=C(N)N=C1N WEFXJAAWRSVZGQ-UHFFFAOYSA-N 0.000 description 1
- WSUHWGUKUNKKTE-UHFFFAOYSA-N 5-[(8-ethoxy-2,2-dimethyl-4-thiophen-2-ylchromen-6-yl)methyl]pyrimidine-2,4-diamine Chemical compound C=1C=2C(C=3SC=CC=3)=CC(C)(C)OC=2C(OCC)=CC=1CC1=CN=C(N)N=C1N WSUHWGUKUNKKTE-UHFFFAOYSA-N 0.000 description 1
- RNIQNGVCKNPQSY-UHFFFAOYSA-N 5-[(8-ethoxy-2,2-dimethyl-4-thiophen-3-ylchromen-6-yl)methyl]pyrimidine-2,4-diamine Chemical compound C=1C=2C(C3=CSC=C3)=CC(C)(C)OC=2C(OCC)=CC=1CC1=CN=C(N)N=C1N RNIQNGVCKNPQSY-UHFFFAOYSA-N 0.000 description 1
- FPZQFLMDHQYCRI-UHFFFAOYSA-N 5-[(8-ethoxy-2,2-dimethyl-4-trimethylsilylchromen-6-yl)methyl]pyrimidine-2,4-diamine Chemical compound C=1C=2C([Si](C)(C)C)=CC(C)(C)OC=2C(OCC)=CC=1CC1=CN=C(N)N=C1N FPZQFLMDHQYCRI-UHFFFAOYSA-N 0.000 description 1
- WKSCFHDSDFFKMP-UHFFFAOYSA-N 5-[(8-ethoxy-2,2-dimethylchromen-6-yl)methyl]pyrimidine-2,4-diamine Chemical compound C=1C=2C=CC(C)(C)OC=2C(OCC)=CC=1CC1=CN=C(N)N=C1N WKSCFHDSDFFKMP-UHFFFAOYSA-N 0.000 description 1
- NMAZEXKWOHKUEC-UHFFFAOYSA-N 5-[(8-methoxy-2,2,4-trimethylchromen-6-yl)methyl]pyrimidine-2,4-diamine Chemical compound C=1C=2C(C)=CC(C)(C)OC=2C(OC)=CC=1CC1=CN=C(N)N=C1N NMAZEXKWOHKUEC-UHFFFAOYSA-N 0.000 description 1
- NDCHMVVBDDMHGV-UHFFFAOYSA-N 5-[(8-methoxy-2,2-dimethyl-4-phenylchromen-6-yl)methyl]pyrimidine-2,4-diamine Chemical compound C=1C=2C(C=3C=CC=CC=3)=CC(C)(C)OC=2C(OC)=CC=1CC1=CN=C(N)N=C1N NDCHMVVBDDMHGV-UHFFFAOYSA-N 0.000 description 1
- UFFTVCXHZSCQLK-UHFFFAOYSA-N 5-[(8-methoxyspiro[chromene-2,4'-piperidine]-6-yl)methyl]pyrimidine-2,4-diamine Chemical compound C=1C=2C=CC3(CCNCC3)OC=2C(OC)=CC=1CC1=CN=C(N)N=C1N UFFTVCXHZSCQLK-UHFFFAOYSA-N 0.000 description 1
- HHZWTNNCGKHFBW-UHFFFAOYSA-N 5-[[4-(3-aminophenyl)-8-ethoxy-2,2-dimethylchromen-6-yl]methyl]pyrimidine-2,4-diamine Chemical compound C=1C=2C(C=3C=C(N)C=CC=3)=CC(C)(C)OC=2C(OCC)=CC=1CC1=CN=C(N)N=C1N HHZWTNNCGKHFBW-UHFFFAOYSA-N 0.000 description 1
- CHCXHCBVPZZVIU-UHFFFAOYSA-N 5-[[4-(3-fluorophenyl)-8-methoxy-2,2-dimethylchromen-6-yl]methyl]pyrimidine-2,4-diamine Chemical compound C=1C=2C(C=3C=C(F)C=CC=3)=CC(C)(C)OC=2C(OC)=CC=1CC1=CN=C(N)N=C1N CHCXHCBVPZZVIU-UHFFFAOYSA-N 0.000 description 1
- QOXCZELHVGAJHP-UHFFFAOYSA-N 5-[[4-(4-aminophenyl)-8-ethoxy-2,2-dimethylchromen-6-yl]methyl]pyrimidine-2,4-diamine Chemical compound C=1C=2C(C=3C=CC(N)=CC=3)=CC(C)(C)OC=2C(OCC)=CC=1CC1=CN=C(N)N=C1N QOXCZELHVGAJHP-UHFFFAOYSA-N 0.000 description 1
- SQHCHQFVGYHHJU-UHFFFAOYSA-N 5-[[8-(cyclopropylmethoxy)-2,2-dimethoxychromen-6-yl]methyl]pyrimidine-2,4-diamine Chemical compound C1=C(CC=2C(=NC(N)=NC=2)N)C=C2C=CC(OC)(OC)OC2=C1OCC1CC1 SQHCHQFVGYHHJU-UHFFFAOYSA-N 0.000 description 1
- FEBHEPJDHDNKGQ-UHFFFAOYSA-N 5-[[8-ethoxy-2,2-dimethyl-4-(2-methylpropyl)chromen-6-yl]methyl]pyrimidine-2,4-diamine Chemical compound C=1C=2C(CC(C)C)=CC(C)(C)OC=2C(OCC)=CC=1CC1=CN=C(N)N=C1N FEBHEPJDHDNKGQ-UHFFFAOYSA-N 0.000 description 1
- MMXCAMXEXPTOAT-UHFFFAOYSA-N 5-[[8-ethoxy-4-(3-fluorophenyl)-2,2-dimethylchromen-6-yl]methyl]pyrimidine-2,4-diamine Chemical compound C=1C=2C(C=3C=C(F)C=CC=3)=CC(C)(C)OC=2C(OCC)=CC=1CC1=CN=C(N)N=C1N MMXCAMXEXPTOAT-UHFFFAOYSA-N 0.000 description 1
- ULGGMITYBWBGBT-UHFFFAOYSA-N 5-[[8-ethoxy-4-(4-ethoxyphenyl)-2,2-dimethylchromen-6-yl]methyl]pyrimidine-2,4-diamine Chemical compound C1=CC(OCC)=CC=C1C(C1=C2)=CC(C)(C)OC1=C(OCC)C=C2CC1=CN=C(N)N=C1N ULGGMITYBWBGBT-UHFFFAOYSA-N 0.000 description 1
- SLWYXRPFYMCNSU-UHFFFAOYSA-N 5-[[8-ethoxy-4-(4-fluorophenyl)-2,2-dimethylchromen-6-yl]methyl]pyrimidine-2,4-diamine Chemical compound C=1C=2C(C=3C=CC(F)=CC=3)=CC(C)(C)OC=2C(OCC)=CC=1CC1=CN=C(N)N=C1N SLWYXRPFYMCNSU-UHFFFAOYSA-N 0.000 description 1
- YKFBVYUPNRNTMZ-UHFFFAOYSA-N 5-[[8-methoxy-2,2-dimethyl-4-(3-nitrophenyl)chromen-6-yl]methyl]pyrimidine-2,4-diamine Chemical compound C=1C=2C(C=3C=C(C=CC=3)[N+]([O-])=O)=CC(C)(C)OC=2C(OC)=CC=1CC1=CN=C(N)N=C1N YKFBVYUPNRNTMZ-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- RUHQQQJPPSIFGB-UHFFFAOYSA-N 8-(cyclopropylmethoxy)-2,2-dimethylchromene-6-carbaldehyde Chemical compound C1=C(C=O)C=C2C=CC(C)(C)OC2=C1OCC1CC1 RUHQQQJPPSIFGB-UHFFFAOYSA-N 0.000 description 1
- AUKUPGKJQLLOMK-UHFFFAOYSA-N 8-ethoxy-2,2-dimethyl-4-(2-methylpropyl)chromene-6-carbaldehyde Chemical compound CC(C)CC1=CC(C)(C)OC2=C1C=C(C=O)C=C2OCC AUKUPGKJQLLOMK-UHFFFAOYSA-N 0.000 description 1
- RODBVVUAFYZUTQ-UHFFFAOYSA-N 8-ethoxy-2,2-dimethyl-4-prop-1-en-2-ylchromene-6-carbaldehyde Chemical compound CC(=C)C1=CC(C)(C)OC2=C1C=C(C=O)C=C2OCC RODBVVUAFYZUTQ-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 229910002666 PdCl2 Inorganic materials 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 229920003110 Primojel Polymers 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 238000003477 Sonogashira cross-coupling reaction Methods 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 238000006619 Stille reaction Methods 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- WMPXPUYPYQKQCX-UHFFFAOYSA-N Sulfamonomethoxine Chemical compound C1=NC(OC)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 WMPXPUYPYQKQCX-UHFFFAOYSA-N 0.000 description 1
- NHUHCSRWZMLRLA-UHFFFAOYSA-N Sulfisoxazole Chemical compound CC1=NOC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1C NHUHCSRWZMLRLA-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- UWCQQTTZXHSDLK-UHFFFAOYSA-N [6-[(2,4-diaminopyrimidin-5-yl)methyl]-8-ethoxy-2,2-dimethylchromen-4-yl]methanol Chemical compound C=1C=2C(CO)=CC(C)(C)OC=2C(OCC)=CC=1CC1=CN=C(N)N=C1N UWCQQTTZXHSDLK-UHFFFAOYSA-N 0.000 description 1
- LHKDGXMCPYADGH-UHFFFAOYSA-N [6-[(2,4-diaminopyrimidin-5-yl)methyl]-8-methoxy-2,2-dimethylchromen-4-yl]methanol Chemical compound C=1C=2C(CO)=CC(C)(C)OC=2C(OC)=CC=1CC1=CN=C(N)N=C1N LHKDGXMCPYADGH-UHFFFAOYSA-N 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 150000001345 alkine derivatives Chemical class 0.000 description 1
- 150000001347 alkyl bromides Chemical class 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 125000002393 azetidinyl group Chemical group 0.000 description 1
- 125000004069 aziridinyl group Chemical group 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000004619 benzopyranyl group Chemical group O1C(C=CC2=C1C=CC=C2)* 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- RMKACVRKUKSWNQ-UHFFFAOYSA-N but-3-yn-2-yloxy(trimethyl)silane Chemical compound C#CC(C)O[Si](C)(C)C RMKACVRKUKSWNQ-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- WBLIXGSTEMXDSM-UHFFFAOYSA-N chloromethane Chemical compound Cl[CH2] WBLIXGSTEMXDSM-UHFFFAOYSA-N 0.000 description 1
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 239000012050 conventional carrier Substances 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000004851 cyclopentylmethyl group Chemical group C1(CCCC1)C* 0.000 description 1
- YNHIGQDRGKUECZ-UHFFFAOYSA-N dichloropalladium;triphenylphosphanium Chemical compound Cl[Pd]Cl.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 125000005879 dioxolanyl group Chemical group 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229910000043 hydrogen iodide Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002632 imidazolidinyl group Chemical group 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229960004903 invert sugar Drugs 0.000 description 1
- 230000026045 iodination Effects 0.000 description 1
- 238000006192 iodination reaction Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000003965 isoxazolidinyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- MJKIOYOGCSQRQO-UHFFFAOYSA-N n-[3-[6-[(2,4-diaminopyrimidin-5-yl)methyl]-8-ethoxy-2,2-dimethylchromen-4-yl]phenyl]acetamide Chemical compound C=1C=2C(C=3C=C(NC(C)=O)C=CC=3)=CC(C)(C)OC=2C(OCC)=CC=1CC1=CN=C(N)N=C1N MJKIOYOGCSQRQO-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- PVWOIHVRPOBWPI-UHFFFAOYSA-N n-propyl iodide Chemical compound CCCI PVWOIHVRPOBWPI-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 125000000160 oxazolidinyl group Chemical group 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 125000003566 oxetanyl group Chemical group 0.000 description 1
- 125000000466 oxiranyl group Chemical group 0.000 description 1
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229960000969 phenyl salicylate Drugs 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000005936 piperidyl group Chemical group 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000003186 propargylic group Chemical group 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 150000003195 pteridines Chemical class 0.000 description 1
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003072 pyrazolidinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- QLULGIRFKAWHOJ-UHFFFAOYSA-N pyridin-4-ylboronic acid Chemical compound OB(O)C1=CC=NC=C1 QLULGIRFKAWHOJ-UHFFFAOYSA-N 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000004426 substituted alkynyl group Chemical group 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004306 sulfadiazine Drugs 0.000 description 1
- ZZORFUFYDOWNEF-UHFFFAOYSA-N sulfadimethoxine Chemical compound COC1=NC(OC)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 ZZORFUFYDOWNEF-UHFFFAOYSA-N 0.000 description 1
- 229960000973 sulfadimethoxine Drugs 0.000 description 1
- 229960000654 sulfafurazole Drugs 0.000 description 1
- 229940101590 sulfamethoxazole 400 mg Drugs 0.000 description 1
- 229950003874 sulfamonomethoxine Drugs 0.000 description 1
- 229960003097 sulfaquinoxaline Drugs 0.000 description 1
- 239000011593 sulfur Chemical group 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- ZAPXTHCEAQVIDX-UHFFFAOYSA-N tert-butyl 4-ethenyl-4-hydroxypiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(O)(C=C)CC1 ZAPXTHCEAQVIDX-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000005958 tetrahydrothienyl group Chemical group 0.000 description 1
- 125000004632 tetrahydrothiopyranyl group Chemical group S1C(CCCC1)* 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 125000001984 thiazolidinyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 125000002053 thietanyl group Chemical group 0.000 description 1
- 125000001730 thiiranyl group Chemical group 0.000 description 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 1
- ARYHTUPFQTUBBG-UHFFFAOYSA-N thiophen-2-ylboronic acid Chemical compound OB(O)C1=CC=CS1 ARYHTUPFQTUBBG-UHFFFAOYSA-N 0.000 description 1
- QNMBSXGYAQZCTN-UHFFFAOYSA-N thiophen-3-ylboronic acid Chemical compound OB(O)C=1C=CSC=1 QNMBSXGYAQZCTN-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 125000004306 triazinyl group Chemical group 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- 229940086542 triethylamine Drugs 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 description 1
- 229960001082 trimethoprim Drugs 0.000 description 1
- JGWFUSVYECJQDT-UHFFFAOYSA-N trimethyl(2-trimethylsilyloxyethoxy)silane Chemical compound C[Si](C)(C)OCCO[Si](C)(C)C JGWFUSVYECJQDT-UHFFFAOYSA-N 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
- C07F7/0814—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00108945 | 2000-04-27 | ||
| EP00108945 | 2000-04-27 | ||
| PCT/EP2001/004541 WO2001083476A1 (en) | 2000-04-27 | 2001-04-20 | Chromenylmethyl pyrimidinediamines as antibacterial agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001252269A1 true AU2001252269A1 (en) | 2001-11-12 |
Family
ID=8168565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001252269A Abandoned AU2001252269A1 (en) | 2000-04-27 | 2001-04-20 | Chromenylmethyl pyrimidinediamines as antibacterial agents |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6818649B2 (de) |
| EP (1) | EP1278742B1 (de) |
| JP (1) | JP4033676B2 (de) |
| KR (1) | KR20020093966A (de) |
| CN (1) | CN1249057C (de) |
| AT (1) | ATE284882T1 (de) |
| AU (1) | AU2001252269A1 (de) |
| BR (1) | BR0110255A (de) |
| CA (1) | CA2405614A1 (de) |
| DE (1) | DE60107832T2 (de) |
| ES (1) | ES2232614T3 (de) |
| MX (1) | MXPA02010518A (de) |
| WO (1) | WO2001083476A1 (de) |
| ZA (1) | ZA200208271B (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI243173B (en) | 1999-11-17 | 2005-11-11 | Akzo Nobel Nv | Spiro[2H-1-benzopyran-2,4'-piperidine] derivatives |
| BRPI0415165A (pt) * | 2003-10-01 | 2007-01-09 | Adolor Corp | composto heterocìclico espirocìclico, composição farmacêutica, método para ligar receptores opióides, métodos para prevenir ou tratar dor, disfunção gastrointestinal, um distúrbio do trato urogenital, um distúrbio imunomodulatório, um distúrbio inflamatório, um distúrbio de função respiratória, ansiedade, distúrbio do humor, um distúrbio relacionado a estresse, distúrbio do sistema nervoso simpático, tosse, e um distúrbio motor, método para tratar uma lesão traumática ao sistema nervoso central, métodos para prevenir ou tratar acidente vascular, arritmia cardìaca, glaucoma, e disfunção sexual, métodos para tratar uma condição selecionada do grupo consistindo de choque, edema cerebral, isquemia cerebral, déficit cerebral após cirurgia cardìaca (bypass) e enxerto, lupus eritematoso sistêmico, doença de hodgkin, doença de sjogren, epilepsia, e rejeição em transplantes de órgão e enxertos de pele, e para tratar dependência de substáncias, métodos para melhorar a sobrevivência de órgãos e células, e cardioproteção após infarto do miocárdio, métodos para reduzir a necessidade de anestesia, para produzir ou manter um estado anestésico, derivado radiomarcado de um composto, derivado isotopicamente marcado de um composto, composto e método de diagnóstico por imagem |
| ES2337496T3 (es) * | 2005-01-19 | 2010-04-26 | Rigel Pharmaceuticals, Inc. | Profarmacos de compuestos de 2,4-pirimidindiamina y sus usos. |
| US7598261B2 (en) | 2005-03-31 | 2009-10-06 | Adolor Corporation | Spirocyclic heterocyclic derivatives and methods of their use |
| EP1770089A1 (de) * | 2005-10-03 | 2007-04-04 | Institut Pasteur | Pyranodibenzofuranderivate mit antimykotischer und antibakterieller Wirkung |
| US7855194B2 (en) | 2006-03-27 | 2010-12-21 | Hoffmann-La Roche Inc. | Pyrimidine, quinazoline, pteridine and triazine derivatives |
| US7576207B2 (en) | 2006-04-06 | 2009-08-18 | Adolor Corporation | Spirocyclic heterocyclic derivatives and methods of their use |
| CN109134493A (zh) * | 2018-09-19 | 2019-01-04 | 浙江师范大学 | 一种具有抗菌活性的2-氧代色烯并噻吩衍生物及其合成方法和应用 |
| CN109988156B (zh) * | 2019-03-12 | 2021-12-28 | 广东中科药物研究有限公司 | 一种氨基嘧啶化合物 |
| CN112824412B (zh) * | 2019-11-21 | 2022-09-16 | 中国科学院大连化学物理研究所 | 手性1′H-螺[吲哚啉-3,4′-吡喃并[2,3-c]吡唑]-2-酮类化合物 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997020839A1 (en) * | 1995-12-04 | 1997-06-12 | F. Hoffmann-La Roche Ag | Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial |
-
2001
- 2001-04-20 US US10/258,777 patent/US6818649B2/en not_active Expired - Fee Related
- 2001-04-20 JP JP2001580904A patent/JP4033676B2/ja not_active Expired - Fee Related
- 2001-04-20 CN CNB018085962A patent/CN1249057C/zh not_active Expired - Fee Related
- 2001-04-20 AT AT01925562T patent/ATE284882T1/de not_active IP Right Cessation
- 2001-04-20 AU AU2001252269A patent/AU2001252269A1/en not_active Abandoned
- 2001-04-20 WO PCT/EP2001/004541 patent/WO2001083476A1/en not_active Application Discontinuation
- 2001-04-20 EP EP01925562A patent/EP1278742B1/de not_active Expired - Lifetime
- 2001-04-20 DE DE60107832T patent/DE60107832T2/de not_active Expired - Lifetime
- 2001-04-20 KR KR1020027014451A patent/KR20020093966A/ko not_active Application Discontinuation
- 2001-04-20 ES ES01925562T patent/ES2232614T3/es not_active Expired - Lifetime
- 2001-04-20 BR BR0110255-9A patent/BR0110255A/pt not_active IP Right Cessation
- 2001-04-20 CA CA002405614A patent/CA2405614A1/en not_active Abandoned
- 2001-04-20 MX MXPA02010518A patent/MXPA02010518A/es unknown
-
2002
- 2002-10-14 ZA ZA200208271A patent/ZA200208271B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2232614T3 (es) | 2005-06-01 |
| MXPA02010518A (es) | 2003-03-10 |
| WO2001083476A1 (en) | 2001-11-08 |
| CA2405614A1 (en) | 2001-11-08 |
| JP2004509839A (ja) | 2004-04-02 |
| ATE284882T1 (de) | 2005-01-15 |
| US6818649B2 (en) | 2004-11-16 |
| BR0110255A (pt) | 2003-01-07 |
| EP1278742A1 (de) | 2003-01-29 |
| CN1249057C (zh) | 2006-04-05 |
| DE60107832D1 (en) | 2005-01-20 |
| JP4033676B2 (ja) | 2008-01-16 |
| KR20020093966A (ko) | 2002-12-16 |
| DE60107832T2 (de) | 2005-06-16 |
| EP1278742B1 (de) | 2004-12-15 |
| CN1507445A (zh) | 2004-06-23 |
| US20030144246A1 (en) | 2003-07-31 |
| ZA200208271B (en) | 2004-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2015284135B2 (en) | Heteroaryl compounds useful as inhibitors of SUMO activating enzyme | |
| JP3117721B2 (ja) | 新規なベンジルピリミジン類 | |
| AU2011274322B2 (en) | Naphth- 2 -ylacetic acid derivatives to treat AIDS | |
| AU2013305390C1 (en) | Dihydropyrimidine compounds and their application in pharmaceuticals | |
| UA125400C2 (uk) | Піролопіримідин як потенціатор трансмембранної провідності при муковісцидозі (cftr) | |
| TW202200554A (zh) | 作為ｙａｐ／ｔａｚ—ｔｅａｄ蛋白—蛋白相互作用抑制劑之聯芳基衍生物 | |
| TW201838966A (zh) | 取代的二氫茚－４－甲醯胺及其類似物以及其使用方法 | |
| CZ2002534A3 (cs) | Inhibitory protein-kináz, farmaceutické prostředky, které je obsahují, a jejich pouľití | |
| WO2009046416A1 (en) | Anilinopyrimidines as jak kinase inhibitors | |
| US6818649B2 (en) | Chromenylmethyl pyrimidinediamines as antibacterial agents | |
| US5656626A (en) | Substituted nitrogen heterocycles | |
| TW201542542A (zh) | 新穎ｐｄｅ４抑制劑 | |
| JP2001514178A (ja) | 抗生性オキサゾリジノン誘導体 | |
| TWI508968B (zh) | 用於治療呼吸道融合性病毒感染的化合物 | |
| MXPA02004443A (es) | 5-bencil-2,4-diaminopirimidinas sustituidas. | |
| AU2013326407A1 (en) | Inhibitors of Viral Replication, Their Process of Preparation and Their Therapeutical Uses | |
| AU2013326408A1 (en) | Inhibitors of viral replication, their process of preparation and their therapeutical uses | |
| JP4048054B2 (ja) | 抗菌活性を有するピリミジニルメチルインドール誘導体 | |
| WO2016204135A1 (ja) | ５員ヘテロ環誘導体 | |
| OA18892A (en) | New hydroxyacid derivatives, a process for their preparation and pharmaceutical compositions containing them. |